Tom Kralj

@MatthewChallis8 @CreekLab @MikeRmitolab Congrats Dr. Challis!!!

My PhD investigating the MoA of new antimalarial compounds has officially been conferred! Thank you @CreekLab, I could not have done it with better people Looking forward to the next adventure in science with @MikeRmitolab, using proteomics to explore all things mitochondria🎉

The depressing state of research in Australia summed up well by @miroastore - make sure to vote to the Libs out on May 21st smh.com.au/education/aust…

@RUNubhav @CreekLab @AnnaDiscovers Thanks Anu!

Great to celebrate the end of 2021 with the in-person graduation of two amazing PhDs @AnnaDiscovers @TomKralj

Thomas Kralj recently submitted his doctoral thesis at Monash University, Melbourne, Australia. He is first author on a recent ToxSci Contemporary Review: doi.org/10.1093/toxsci… Meet Tom: instagram.com/p/CTz9cBuMiIE/ @TomKralj @CreekLab @MIPS_Australia @UNCPharmacy

Wow, they chose a great image for the front cover of this issue!

Link to article: academic.oup.com/toxsci/article…

I got an image from my article featured on the front of @Toxsci!!!!!! 😃😃😃 #dili #liver #metabolomics

Why apply for PARCDT funding? Aside from expertise breadth, more robust research, new techniques, students “have the opportunity to collaborate with your collaborators’ collaborators,” in the words of co-mentored PhD Candidate Tom Kralj.